What is Better for Weight Loss: Ozempic or Wegovy?

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic and Wegovy both deliver the same active ingredient—semaglutide—yet they represent fundamentally different treatment paths. Ozempic was developed to manage type 2 diabetes and reduce cardiovascular risk, while Wegovy received FDA approval specifically for chronic weight management in adults with obesity or overweight status. The clinical evidence shows semaglutide reduces body weight by 15–22% over 68 weeks when combined with lifestyle changes.

Understanding the Difference Between Ozempic and Wegovy

Ozempic and Wegovy both activate GLP-1 receptors in the brain and pancreas to regulate appetite and blood sugar. The chemical composition is identical, but the medications carry different brand names, FDA-approved indications, and pricing models. Ozempic targets diabetes management and cardiovascular protection, whereas Wegovy targets weight loss as a standalone indication. This distinction affects insurance coverage, cost per injection, and how healthcare providers prescribe the medication.

Both medications are available as once-weekly subcutaneous injections. Users gradually increase their dose over 16 weeks during the initial titration phase, starting at 0.25 mg and stepping up based on tolerability. The maintenance phase typically ranges from 1.7 mg to 2.4 mg weekly. Clinical trials demonstrate that higher maintenance doses produce greater weight reduction, with some participants reaching 22% body weight loss at the 2.4 mg dose level.

Semaglutide Injection Cost: Wegovy Pricing vs. Compounded Options

Wegovy's brand-name list price often exceeds $900–$1,500 per month at retail pharmacies, and insurance coverage remains inconsistent across plans. Many insurers classify Wegovy as a lifestyle medication rather than a medically necessary treatment, resulting in high out-of-pocket costs or coverage denials. This pricing barrier has driven many patients toward compounded semaglutide as a more affordable alternative. PlexusDx offers compounded semaglutide injection through licensed 503A pharmacies at a flat rate at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no flat per-compound pricing increases as your treatment progresses.

Ozempic's retail cost similarly ranges from $800–$1,200 monthly when prescribed off-label for weight loss, though some diabetes insurance plans provide partial coverage. Compounded semaglutide bypasses brand markup while delivering the same active pharmaceutical ingredient from regulated pharmacies. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorizations. HSA and FSA accounts are eligible for PlexusDx semaglutide, providing additional tax-advantaged savings for eligible enrollees.

How Semaglutide Works for Weight Loss and Metabolic Health

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone that signals fullness to the brain's appetite centers and slows stomach emptying. By binding to GLP-1 receptors in the hypothalamus and elsewhere, semaglutide reduces hunger, decreases food cravings, and promotes sustained calorie deficit without severe restriction. Studies show that 68% of participants achieved at least 5% body weight reduction, while 45% exceeded 15% weight loss. The metabolic benefits extend beyond weight loss—improved insulin sensitivity, reduced blood pressure, and better lipid profiles emerge within weeks of consistent use.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR and FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Side Effects, Safety Profile, and What to Expect

Common side effects of semaglutide include nausea, vomiting, diarrhea, and constipation, particularly during dose escalation. Most patients report that gastrointestinal symptoms diminish after the first 2–4 weeks at each dose level as the body adapts. Serious but rare adverse events include acute pancreatitis, gallbladder issues, and thyroid concerns—conditions that require medical monitoring. Patients with a personal or family history of medullary thyroid cancer should not use semaglutide, as animal studies suggest a potential risk.

Both Ozempic and compounded semaglutide carry identical safety profiles because they contain the same active ingredient. The difference lies in manufacturing oversight: PlexusDx sources compounded semaglutide exclusively from licensed 503A pharmacies, which maintain strict compounding standards and quality assurance. Your doctor should monitor blood glucose levels, kidney function, and any symptoms of pancreatitis during treatment. Regular check-ins allow dose adjustments and side-effect management to maximize your safety and weight loss success.

Choosing Between Ozempic, Wegovy, and Compounded Semaglutide

If your primary goal is weight loss without diabetes, Wegovy is the FDA-approved choice, but its high cost and insurance barriers make it inaccessible for many patients. Ozempic works identically for weight loss but carries an off-label designation and similar pricing challenges. Compounded semaglutide provides the same active ingredient through licensed pharmacies at a fraction of the cost, making it a practical option for underinsured and uninsured individuals. PlexusDx's transparent, flat pricing model ($189 starting rate with no dose escalation fees) removes the financial guesswork and ensures affordability throughout your weight loss journey.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as Wegovy or Ozempic?

Yes. Compounded semaglutide contains the identical active pharmaceutical ingredient as both Wegovy and Ozempic, provided it comes from a licensed 503A compounding pharmacy. Clinical efficacy depends on the molecule itself, not the brand or manufacturer. PlexusDx sources only from regulated 503A facilities, ensuring purity and potency equivalent to brand-name products at a lower cost.

Why does PlexusDx keep pricing flat as my dose increases?

PlexusDx's pricing model reflects the reality that dose adjustments are medically necessary, not optional upgrades. Your dose may need to go up as your body adjusts and weight plateaus occur, but your monthly cost remains flat at $189/mo month-to-month, or from $149/mo on the 6-month plan. This removes the financial penalty for therapeutic progression and ensures affordability regardless of whether you finish at 0.5 mg or 2.4 mg weekly.

How does genetic testing improve my semaglutide results?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Will insurance cover PlexusDx compounded semaglutide?

PlexusDx requires no insurance and charges a flat monthly rate at $189/mo month-to-month, or from $149/mo on the 6-month plan. However, if you have an HSA or FSA account, these funds are eligible to cover PlexusDx treatment. PlexusDx serves all 50 states without membership fees or prior authorization requirements, making weight loss medication accessible regardless of insurance status.

What happens if I experience significant nausea or other side effects?

Nausea typically resolves within 2–4 weeks as your body adjusts to each dose level. Your PlexusDx provider can slow your dose escalation, adjust your maintenance dose downward, or recommend dietary modifications to manage symptoms. In rare cases where side effects persist, alternative GLP-1 medications like tirzepatide (available through PlexusDx) may offer better tolerability while maintaining similar weight loss benefits.

Related Reading

• Wegovy For Weight Loss 2
• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Wegovy Weight Loss Pills

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.